Recent Updates
Recently added Catalysts
FHTX Positive Sentiment Score: 75/100

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

Wednesday, August 27, 2025 1 min read
Key Takeaway: Foghorn Therapeutics Inc. will participate in three upcoming investor conferences: Citi's 2025 Biopharma Back to School Summit, the 2025 Wells Fargo Healthcare Conference, and the Morgan Stanley 23rd Annual Global Healthcare Conference. Management will engage in one-on-one meetings at each event, enhancing investor relations and company visibility. The company is recognized for its innovative Gene Traffic Control platform aimed at addressing serious diseases, with an initial focus on oncology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in three major investor conferences highlights company visibility.
  • Emphasis on a pioneering approach to gene therapy suggests innovative potential.
  • Focus on oncology aligns with strong market demand for cancer treatments.

Full Press Release Details

CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in Citi’s 2025 Biopharma Back to School Summit, 2025 Wells Fargo Healthcare Conference, and Morgan Stanley 23rd Annual Global Healthcare Conference. With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.
Citi’s 2025 Biopharma Back to School Summit
Date: Wednesday, September 3, 2025
Management will participate in one-on-one meetings
2025 Wells Fargo Healthcare Conference
Date: Thursday, September 4, 2025
Management will participate in one-on-one meetings
Morgan Stanley 23rd Annual Global Healthcare Conference
Date: Monday, September 8, 2025
Management will participate in one-on-one meetings
About Foghorn Therapeutics
Karin Hellsvik, Foghorn Therapeutics Inc.
khellsvik@foghorntx.com

Frequently Asked Questions

What is Foghorn Therapeutics focused on?

Foghorn Therapeutics targets abnormal gene expression to develop treatments.

When is the Citi 2025 Biopharma Summit?

The Citi 2025 Biopharma Summit is on September 3, 2025.

What conferences is Foghorn management attending?

Foghorn management will attend Citi, Wells Fargo, and Morgan Stanley conferences.

How does Foghorn aim to transform healthcare?

Foghorn aims to transform healthcare through its Gene Traffic Control® platform.

Who can be contacted for more information?

Karin Hellsvik is the contact for more information at Foghorn Therapeutics.

Tags: FHTX Viatris Investor Conferences Healthcare Foghorn Therapeutics biotechnology investor conferences oncology
Last updated: Aug 27, 2025